Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06847607 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Multicenter Prospective Study of Iptacopan in the Treatment of Refractory/Relapsed Autoimmune Hemolytic Anemia (AIHA)

StatusNot Yet Recruiting
PhaseNot applicable
SponsorBing Han
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 26, 2025 (before its estimated October 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
Bing Han
3 trials monitored
See all monitored trials
To evaluate the efficacy and safety of ipecopam in the treatment of refractory/relapsed AIHA.
Trial Details
NCT Number NCT06847607
Lead Sponsor Bing Han
Conditions
(from sponsor)		 AIHA - Warm Autoimmune Hemolytic Anemia, AIHA - Cold Autoimmune Hemolytic Anemia
Related terms Anemia, Hemolytic, Autoimmune
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov